Healthcare Tech

Former Merck CEO Ken Frazier, famous for building the drugmaker into one of the world’s biggest cancer companies, shed his pharma garb in his first public appearance since starting a new role with the venture capital giant General Catalyst. In July, General Catalyst appointed Frazier, who remains the executive chairman of Merck, as head of

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.  Noom gets in the mental health mood Noom, the popular weight loss company that recently raised $540 million, is taking its first big step toward becoming

As the digital health sector teems with new entrants, another virtual care startup is stepping into the fray. With three digital health veterans at the helm, primary care company Marley Medical launched Thursday with a promise to treat chronic conditions with an array of remote services and a team-based approach to care. The startup, founded

Five months ago, weight loss company Noom announced $540 million in funding, dwarfing its previous investments. With locked-down users flocking to its app, revenues in 2020 had surged to $400 million, and the company made an ambitious pitch: It would spend the money to expand its behavioral change approach to other conditions, including diabetes, hypertension,

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science

As the country grapples with both the Covid-19 pandemic and the ongoing opioid crisis, chronic pain management has become more challenging than ever. Traditional therapies for chronic pain often rely on opioid-based treatments that run an outsized risk of addiction. Other treatment options include physical therapy, implants, and steroid injections, but these require frequent visits

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.  Quicker autism diagnosis using data Autism spectrum disorder is often diagnosed years later than it could be. In a development that could help accelerate

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.  A nonprofit forms to build an app marketplace One of modern medicine’s biggest market failures is the lack of a common data language to

On a buying streak, hybrid care company Carbon Health on Tuesday purchased Alertive Healthcare, a remote monitoring startup whose connected devices include blood pressure cuffs, electrocardiograms, and pulse oximeters. The purchase strengthens the company’s home care portfolio and marks its second acquisition of a virtual care startup after its June purchase of digital diabetes clinic

It’s one of the biggest market failures in modern medicine. The lack of a widely shared data language is effectively blocking adoption of innumerable software applications designed to make health care cheaper, more effective, and personal. On Tuesday, three large health systems formed a new nonprofit company to fill that gap. The venture, dubbed Graphite

On the surface, there’s little about Whitfield Regional Hospital that would make it a safety net for Alabama’s sickest Covid-19 patients. It has a small ICU with eight beds, and no critical care doctors on staff. The rural hospital has spent decades focused on caring for the community surrounding Demopolis, population 7,000, in the heart

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science

Think of it as digital health’s chicken and egg problem. Which comes first: national distribution of your algorithm, or clinical evidence that it works? For a startup, it is almost impossible to have one without the other. The medical artificial intelligence company Dascena is among many early-stage companies in the throes of this debate. It

The surgical robot market, long dominated by one company, has a new entrant hoping to disrupt the industry with a more immersive, 3D experience for surgeons ’ even as the need for surgical robots in most procedures remains hotly debated. Robot-assisted surgery has boomed in the past 20 years, led by Intuitive, the company that

Despite the wide-ranging expansion of telehealth in the past year, there is still a broad swath of the U.S. population it has largely failed to reach: the 57 million people in rural parts of the country. Even now, as employers rush to add virtual care to their benefits, many telehealth companies have avoided rural areas.

A new study that infected willing participants with common cold and flu viruses provides the most rigorous evidence yet that wearable health monitors could predict infections, even before a person starts experiencing symptoms. If the wearables can similarly predict infections in real-world conditions, the technology could add to existing disease surveillance and testing methods. But

Artificial intelligence may seem like some amorphous, all-knowing entity that could outperform humans at even the most complex of tasks. But behind-the-scenes, humans must spend countless hours cleaning data and teaching these algorithms to “think.” Hari Trivedi is an assistant professor at the department of radiology and imaging services at Emory University. In this video,

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.  How Epic’s sepsis algorithm went off the rails Epic Systems’ algorithm to give doctors early warning of sepsis is failing to reliably detect the

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Log In | Learn More What is it? STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science

At the opening of each of her clinics, there’s a moment when Carolyn Witte, the founder and chief executive officer of women’s health startup Tia, holds her breath. “We call it the ’shoulder-drop moment,’” Witte told STAT. During those few seconds, as a patient is opening the doors to one of Tia’s offices, Witte watches

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.  The Ther-AHHH-nos trial continues Two key themes emerged in the last week of Elizabeth Holmes’ trial. One, judge Edward Davila steadfastly refuses to pronounce Theranos correctly. Two,

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.  Old data, new tricks Atropos Health, a new company spun out from Stanford on Wednesday, hopes to succeed in one of the elusive challenges of digital

A company is launching out of Stanford University on Wednesday to tackle one of the most enduring challenges of digitized medicine: How do you apply data from past patients to inform the care of new ones? The company, named Atropos Health, is seeking to commercialize a consultation service designed to use mountains of existing data

A catalyzing new review found virtually no research into ethics, security, and data rights of digital health measures ’ a worrying trifecta of blind spots for a field and an industry that will need the public’s trust to make a difference in health outcomes. The promise of digital health measures like movement and heart rate

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.  Holmes trial set to resume, with more insider testimony The fraud trial of Elizabeth Holmes is scheduled to resume today after Friday’s proceedings were canceled due to a

“Can you give me a thumbs up?” the surgeon asks Jerry Majetich, an Iraq War veteran, during a checkup this spring at a Boston hospital. “Can you make me a fist? And extend your fingers?” It is an odd, even jarring, series of requests to make of a patient whose right arm has been amputated

After building Facebook’s search bar into a pivotal part of its platform, Tom Stocky is setting his sights on a new target: biology. The onetime tech executive decided to switch tracks after taking a weekly biotech class at Stanford. “I was inspired. I thought, maybe there’s something I can do to deliver medications faster to